NCT06247592

Brief Summary

In this study, the effect of nerve blockade and radiofrequency treatment applied to the nerve on pain in chronic migraine patients will be investigated. Occipital nerve blockade group (control group): Depending on the location of the pain, blockade will be applied unilaterally or bilaterally with 5 cc of 2% prilocaine for each sıde. Pulse Radiofrequency application to the greater occipital nerve will be applicated after radiofrequency cannula placed near the greater occipital nerve location with 42 degree, for 240 seconds.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 26, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 5, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2024

Completed
Last Updated

February 8, 2024

Status Verified

February 1, 2024

Enrollment Period

6 months

First QC Date

January 5, 2024

Last Update Submit

February 7, 2024

Conditions

Keywords

chronic migrainegreater occipital nerve blockpulse radio frequencypain management

Outcome Measures

Primary Outcomes (1)

  • Pain Relief

    Compare the efficacy of blockade procedure applied to the greater occipital nerve with pulse radiofrequency therapy in terms of pain relief with Visual Analog Scale in chronic migraine patients.The visual analog scale (VAS) is numbered from 0 to 10. 10 is the most severe pain 0: no pain at all

    1 and 3 months

Secondary Outcomes (1)

  • Disability, Quality of life

    1 and 3 months

Study Arms (2)

Radiofrequency group

EXPERIMENTAL

Pulse radiofrequency will be applied at 42 degrees for 240 seconds with a channel placed near the greater occipital nerve.

Procedure: Greater occipital nerve pulse radiofrequency

Block group

ACTIVE COMPARATOR

Nerve blockade will be applied to the greater occipital nerve with 5 cc 2% prilocaine.

Procedure: Greater occipital nerve block

Interventions

Pulse Radiofrequency application to the greater occipital nerve will be applicated after radiofrequency cannula placed near the greater occipital nerve location at 42 degree, for 240 seconds.

Block group

The greater occipital nerve will be blocked with 5 cc 2% prilocaine.

Radiofrequency group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients between 18-60 years of age diagnosed with chronic migraine according to IHS criteria

You may not qualify if:

  • Pregnancy
  • Major psychiatric disorder
  • Bleeding diathesis
  • Local infection
  • Allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Esra Ertilav

Aydin, 09100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

HeadacheBites and StingsAgnosia

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPoisoningChemically-Induced DisordersWounds and InjuriesPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Officials

  • Esra Ertilav

    Aydin Adnan Menderes University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Esra Ertilav, Assoc.Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc.Prof.

Study Record Dates

First Submitted

January 5, 2024

First Posted

February 8, 2024

Study Start

September 26, 2023

Primary Completion

March 10, 2024

Study Completion

April 10, 2024

Last Updated

February 8, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

YES

Locations